Prodia (PRDA IJ) - Increasingly Esoteric
Prodia is shifting in a meaningful way towards esoteric testing, which commands significantly higher revenues plus it is building out its genomic...
168 Views
Prodia (PRDA IJ) - Back to Core Testing
Prodia (PRDA IJ) FY2022 results saw declines in revenues and profits but from a COVID-high base and the numbers are now well-above 2019, with...
474 Views
Prodia (PRDA IJ) - A Standout in Diagnostics
Prodia (PRDA IJ) stands out in terms of its strong market positioning and track record together with attractive valuations, especially versus...
337 Views
Prodia (PRDA IJ) - Diagnosing a Return to Healthy Profits
Prodia (PRDA IJ) is significantly cheaper than its Indian comparables, trading on half the valuation, despite being a high-quality player tapping...
533 Views
Prodia (PRDA IJ) - Going Digital with Precision
Prodia (PRDA IJ) remains one of our top healthcare picks in Indonesia, with rising health consciousness driving higher demand for testing....
641 Views